Natural Product: NPC53744

Natural Product IDNPC53744
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Olean-12-En-3Bea,15Alpha,24-Triol
IUPAC Name (3S,4S,4aR,6aR,6bS,7S,8aR,12aR,14aR,14bR)-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,7-diol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL489552
PubChem CID 14167260
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey DMUKCLRLPXYUKD-LICRDSFHSA-N
Standard InCHI InChI=1S/C30H50O3/c1-25(2)14-15-26(3)17-24(33)30(7)19(20(26)16-25)8-9-22-27(4)12-11-23(32)28(5,18-31)21(27)10-13-29(22,30)6/h8,20-24,31-33H,9-18H2,1-7H3/t20-,21+,22+,23-,24-,26+,27-,28+,29+,30-/m0/s1
SMILES OC[C@@]1(C)[C@@H](O)CC[C@]2([C@H]1CC[C@@]1([C@@H]2CC=C2[C@@]1(C)[C@@H](O)C[C@@]1([C@H]2CC(CC1)(C)C)C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   458.38 Volume:   508.388
?
Van der Waals volume.
Dense:   0.902 LogP:   4.176
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.974
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.798
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   26.0
TPSA:   60.69
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   3.0 Rings:   5.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.415 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.994 Fsp3:   0.933
MCE-18:   104.897
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.624 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.04
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.473 Promiscuous compounds:   0.114

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.3 MDCK Permeability:   -4.935
Pgp-inhibitor:   0.311 Pgp-substrate:   0.102
PAMPA:   0.97
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.984 30% Bioavailability (F30%):   0.283
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   1.0 MRP1:   0.941
Plasma Protein Binding (PPB):   94.074% Volume Distribution (VD):   -0.189
Fu: 5.294%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.841 BCRP inhibitor:   0.617
BSEP inhibitor:   0.974

ADMET: Metabolism

CYP1A2-inhibitor:   0.064 CYP1A2-substrate:   0.105
CYP2C19-inhibitor:   0.956 CYP2C19-substrate:   0.647
CYP2C9-inhibitor:   0.057 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.079 CYP2D6-substrate:   0.004
CYP3A4-inhibitor:   0.205 CYP3A4-substrate:   0.764
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.695
HLM stability:   0.734
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.985 Half-life (T1/2):  0.679

ADMET: Toxicity

hERG Blockers:  0.052 hERG Blockers (10um):  0.321
Human Hepatotoxicity (H-HT):  0.633 Drug-induced Liver Injury (DILI):  0.222
AMES Toxicity:  0.578 Rat Oral Acute Toxicity:  0.806
Maximum Recommended Daily Dose:  0.613 Skin Sensitization:  0.99
Carcinogencity:  0.988 Eye Corrosion:  0.011
Eye Irritation:  0.613 Respiratory Toxicity:  0.943
Drug-induced Neurotoxicity:  0.208 Ototoxicity:  0.462
Hematotoxicity:  0.724 Drug-induced Nephrotoxicity:  0.882
Genotoxicity:  0.884 RPMI-8226 Immunitoxicity:  0.096
A549 Cytotoxicity:  0.917 Hek293 Cytotoxicity:  0.831
BCF:   2.065
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.916
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.133
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.633
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18290 Phyllanthus flexuosus Species Phyllanthaceae Eukaryota n.a. n.a. n.a. PMID[11754608]
NPO18290 Phyllanthus flexuosus Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18290 Phyllanthus flexuosus Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18290 Phyllanthus flexuosus Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18290 Phyllanthus flexuosus Species Phyllanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1044 Individual protein DNA topoisomerase II alpha Homo sapiens IC50 = 38700.0 nM PMID[21846091]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC53744 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8333 Intermediate Similarity NPC474989
0.7544 Intermediate Similarity NPC196753
0.6557 Remote Similarity NPC480924
0.619 Remote Similarity NPC230295
0.619 Remote Similarity NPC238992
0.619 Remote Similarity NPC98386
0.6167 Remote Similarity NPC290598
0.6167 Remote Similarity NPC30590
0.6032 Remote Similarity NPC253807
0.6032 Remote Similarity NPC158662
0.5873 Remote Similarity NPC101475
0.5781 Remote Similarity NPC478657
0.5692 Remote Similarity NPC253402
0.5692 Remote Similarity NPC470588
0.5625 Remote Similarity NPC311078
0.5625 Remote Similarity NPC237344
0.5625 Remote Similarity NPC34177
0.5588 Remote Similarity NPC213412
0.5493 Remote Similarity NPC480919
0.5303 Remote Similarity NPC235341
0.5294 Remote Similarity NPC246708
0.5286 Remote Similarity NPC270768
0.5286 Remote Similarity NPC59263
0.5286 Remote Similarity NPC210106
0.5278 Remote Similarity NPC263393
0.5211 Remote Similarity NPC126369
0.5211 Remote Similarity NPC470589
0.5211 Remote Similarity NPC111110
0.5125 Remote Similarity NPC237503
0.507 Remote Similarity NPC488519
0.5065 Remote Similarity NPC480920

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC53744 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5507 Remote Similarity NPD7645 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data